about
A single amino acid residue can determine the sensitivity of SERCAs to artemisininsA Randomised, Double Blind, Placebo-Controlled Pilot Study of Oral Artesunate Therapy for Colorectal CancerArtemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in UgandaArtemisinins: their growing importance in medicineCryo-EM structure of the Plasmodium falciparum 80S ribosome bound to the anti-protozoan drug emetineSafety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina FasoScreening of traditionally used plants for in vivo antimalarial activity in mice.Water-soluble polymer-drug conjugates for combination chemotherapy against visceral leishmaniasis.Tolerability and efficacy of a pediatric granule formulation of artesunate-mefloquine in young children from Cameroon with uncomplicated falciparum malariaDynamics of Plasmodium falciparum parasitemia regarding combined treatment regimens for acute uncomplicated malaria, Antioquia, Colombia.In vitro and in vivo interactions between miltefosine and other antileishmanial drugsChemotherapeutic interaction between Khaya grandifoliola (WELW) CDC stem bark extract and two anti-malarial drugs in mice.Antimalarial activity of the myxobacterial macrolide chlorotonil a.Modelling the time course of antimalarial parasite killing: a tour of animal and human models, translation and challengesDiscovery, mechanisms of action and combination therapy of artemisininDrug repositioning as a route to anti-malarial drug discovery: preliminary investigation of the in vitro anti-malarial efficacy of emetine dihydrochloride hydrate.Structures, targets and recent approaches in anti-leishmanial drug discovery and development.Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese childrenPlasmodial sugar transporters as anti-malarial drug targets and comparisons with other protozoa.Structural studies of vacuolar plasmepsinsArtemisinins.Malaria in the post-genomics era: light at the end of the tunnel or just another train?Adherence to a six-dose regimen of artemether-lumefantrine among uncomplicated Plasmodium falciparum patients in the Tigray Region, EthiopiaIntermittent preventive treatment for malaria in pregnancy in Africa: what's new, what's needed?Artesunate--amodiaquine combination therapy for falciparum malaria in young Gabonese children.Randomized controlled trial of fosmidomycin-clindamycin versus sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malariaRandomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar.Efficacy and Safety of Artesunate-Amodiaquine versus Artemether-Lumefantrine in the Treatment of Uncomplicated Plasmodium falciparum Malaria in Sentinel Sites across Côte d'Ivoire.Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.Hematoxicity of amodiaquine in sprague-dawley rats.How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?Investigating antimalarial drug interactions of emetine dihydrochloride hydrate using CalcuSyn-based interactivity calculations.Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway.Efficacy of amodiaquine in the treatment of uncomplicated falciparum malaria in young children of rural north-western Burkina Faso.Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.The manzamines as an example of the unique structural classes available for the discovery and optimization of infectious disease controls based on marine natural products.Degradation of Artemisinin-Based Combination Therapies Under Tropical ConditionsProspects for the treatment of drug-resistant malaria parasites.Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon.
P2860
Q22061863-87D5F67A-A399-4EB7-B636-D9E901CA316BQ22061945-BD4339BE-5982-4E43-87EB-EEFE1BCA2DE2Q24815752-DB85FEF6-578B-435D-9BD6-BDA4058E3608Q27489880-56732002-7633-452F-BD3B-FA5D9B492D3BQ27684255-3588DE1C-0A5B-4685-AFA9-51FB43B016D7Q28472182-FC25FB80-F846-458B-9159-4CD6AA1995D6Q33630564-47C5718C-51B4-4202-9071-46BA0DEAC7EBQ33823803-CFD60618-AFD1-48FF-B4E3-8AE9E999160EQ33880614-2782F00B-5231-410B-9032-65887CB6C136Q34030238-DC444A32-91C6-4194-B93A-540CAC200F65Q34301638-0BB34E97-24BA-4459-80C9-54781814837BQ34421668-26BE6D4F-40F0-40F5-90CF-230F641538CAQ34596488-59FE163B-026E-4EBE-96BD-C9A10D5EEC27Q34953705-FBA37C3B-5B53-467D-8108-04EB2D971CC5Q35006418-99CEF5B8-7F52-43AD-B6A8-DBBE467702BDQ35012561-4E8C6E8D-A91F-4662-B067-66B99356ECA3Q35012968-AA2B9040-ED18-4696-8A6E-4D92FDB9D133Q35031417-B310F9E0-FF46-44F0-964E-02A2C98F9117Q35038632-F840E3ED-8378-42E8-A09B-675AAFF53BC8Q35102950-3CB61D3D-A8E1-4D4D-B078-77A178A69301Q35159276-D4692FB6-9BCC-45AE-AD28-56B393518AD0Q35521094-C8E280B4-4107-448F-B73E-1568B95B7363Q35522550-6DA7CC43-617D-4351-871E-6EDCF184E0D8Q35642797-0BF14764-365F-4A14-AA7D-C2C94318D627Q35652102-674A1B73-A69D-405A-8C25-7CBCC60CF1E0Q35695222-ACA16F0E-68E7-4015-8B23-D2B34A061319Q35759028-4A01CF07-2E27-43E4-8B76-7505A78312A9Q35834329-FEA4EEEA-6A52-43A5-8DE9-A526A065E63EQ35996318-B8B87AFC-128D-4351-B7BC-6613B80AC7D1Q36018719-49971435-C81C-4785-9FF6-B8AAE97432E1Q36073326-53848FBD-935D-414D-95BE-4BC4B7824FD3Q36076111-49AD7620-535F-43A9-B045-1DD07DABA3EDQ36296803-61643C05-CEC5-4A5E-8246-D988DD575932Q36339126-9ED546E4-102F-4089-B583-A2EF0292A7FCQ36606690-BF79F5B7-31FC-4A36-90ED-4C571657D5FBQ36740553-60B80E67-287D-4B76-B24A-9DF278990924Q36754650-F566DA9D-89E5-485B-B83E-5B97A1944E43Q36869659-79D25CDA-5655-4D2C-9F04-8A27861E351AQ36895758-88DB6108-9885-4B11-9C20-AEAE8D968BCDQ36981978-9476FCA9-BBB8-403D-9A7C-B511EFE47920
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Antimalarial combinations.
@ast
Antimalarial combinations.
@en
type
label
Antimalarial combinations.
@ast
Antimalarial combinations.
@en
prefLabel
Antimalarial combinations.
@ast
Antimalarial combinations.
@en
P1433
P1476
Antimalarial combinations.
@en
P304
P356
10.1016/S0140-6736(04)16680-4
P407
P577
2004-07-01T00:00:00Z